NarinderPBhallaMD

Cardiology • Wilmington, DE

Interventional Cardiology

SVP, Worldwide Medical Affairs Head of Cardiovascular and Established Brands Bristol Myers Squibb Lawrenceville, New Jersey, USA

Join to view full profile

Dr. Bhalla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhalla's full profile

Already have an account?

Office
1800 Concord Pike
Wilmington, DE 19803
Phone+1 302-886-3000

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 1995 - 1996
NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 1992 - 1995
NYU Grossman School of MedicineResidency, Internal Medicine, 1988 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1988

Certifications & Licensure

NY State Medical License 1990 - 2025
VA State Medical License 1999 - 2018
AL State Medical License 2008 - 2017

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Start of enrollment: 2012 Jun 07
Completed
Phase 3
ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Completed
Not Applicable

Publications & Presentations

PubMed

1 citations
Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample.
Benjamin D Horne, Nipun Atreja, John Venditto, Thomas Wilson, Joseph B Muhlestein
Journal of Clinical Medicine. 2024-05-11
2 citations
Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis.
Tope Olufade, Nipun Atreja, Narinder Bhalla, John Venditto, Durgesh Bhandary
Cardiology and Therapy. 2021-08-13
8 citations
New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims).
Kamil F. Faridi, Narinder Bhalla, Nipun Atreja, John Venditto, Naeem D. Khan
The American Journal of Cardiology. 2021-05-27

Press Mentions

Retrospective Observational Study Assessing Real-World Clinical Impact of Switching or Continuing Eliquis® or Rivaroxaban Presented at the European Society of Cardiology (ESC) Congress 2023August 26th, 2023

Professional Memberships

American College of Cardiology - ACC
Member